Last updated: March 8, 2024
Sponsor: Fraser Health
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain
Dementia
Treatment
SedLine
Clinical Study ID
NCT06019078
H23-01671
Ages 17-110 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Admitted to ICU
- Receive mechanical ventilator support during ICU stay
- Require IV sedation or analgesic while ventilated
- Discharged home from the hospital
- Use of pEEG for sedation or analgesic titration
- Able to read and speak English
- Mechanically ventilated greater than 48 hours
- Aged 17 years +1 day or greater
- Consent to participate
- Participants need a computer with a keyboard, internet access, and email access forthe questionnaires and assessment and be able to use computer and internet.
Exclusion
Exclusion Criteria:
- Deceased during hospitalization
- Intubated at a hospital not included within the study > 12 hours
- Discharge to rehabilitation facility, long term care, or other outpatient setting
- Inability to provide informed consent
- Currently enrolled in any other research study involving drugs or devices
- Is unable to be screened for delirium during ICU admission.
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: SedLine
Phase:
Study Start date:
January 31, 2024
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
Abbotsford Regional Hospital
Abbotsford, British Columbia V2S0C2
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.